Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€18.40

€18.40

-1.630%
-0.3
-1.630%
-
 
27.05.24 / Tradegate WKN: A3CUMB / Name: Stevanato Group S.p.a. / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Stevanato Group S.p.a. Stock

A loss of -1.630% shows a downward development for Stevanato Group S.p.a..

Pros and Cons of Stevanato Group S.p.a. in the next few years

Pros
?
S********** s********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

News

Stevanato Group Appoints Franco Stevanato Chief Executive Officer, Succeeding Franco Moro: https://mms.businesswire.com/media/20240528385017/en/2142378/5/F_Stevanato.jpg
Stevanato Group Appoints Franco Stevanato Chief Executive Officer, Succeeding Franco Moro


Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries

Stevanato Group Announces Results of Annual General Meeting: https://mms.businesswire.com/media/20220601006234/en/1474001/5/JPG_Logo_SG_RGB.jpg
Stevanato Group Announces Results of Annual General Meeting


Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries today

Stevanato Group to Present at Upcoming Investor Conferences: https://mms.businesswire.com/media/20220601006234/en/1474001/5/JPG_Logo_SG_RGB.jpg
Stevanato Group to Present at Upcoming Investor Conferences


Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries